Atraverse Medical, a medical device company secures $12.5million in seed funding. This financing included investment from physicians, reputable venture investors, and successful medtech entrepreneurs.
The money will be used by the firm to further its early commercialization plans and increase its R&D activities. Atraverse Medical, led by CEO John Slump, announced that its HOTWIRETM radiofrequency (RF) guidewire has received FDA clearance.
Read also – [Funding News] TX-based Yendo Secures $165Million in funding
A cutting-edge tool developed by Drs. Steven Mickelsen and Eric Sauter, co-founders of Atraverse, that allows for zero exchange left-heart access and serves as a rail for catheter-based treatment systems. The company’s left-heart access technology is getting closer to being commercialised with this major accomplishment.
About Atraverse Medical
Atraverse Medical is a medical device company pioneering next-generation left-heart access technology. The company’s proprietary HOTWIRE™ system, featuring universal sheath compatibility and optimized RF technology, aims to enhance outcomes and streamline workflows for physicians treating cardiovascular disease in millions of patients worldwide.
